Kenvue Inc. $KVUE Shares Acquired by Carmignac Gestion

Carmignac Gestion boosted its stake in Kenvue Inc. (NYSE:KVUE) by 166.8% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 420,432 shares of the company’s stock after acquiring an additional 262,858 shares during the quarter. Carmignac Gestion’s holdings in Kenvue were worth $8,034,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of KVUE. Empirical Finance LLC lifted its stake in shares of Kenvue by 9.5% in the 2nd quarter. Empirical Finance LLC now owns 31,023 shares of the company’s stock worth $593,000 after acquiring an additional 2,698 shares during the period. Nykredit A S acquired a new position in shares of Kenvue during the second quarter valued at approximately $4,497,000. Amundi raised its holdings in Kenvue by 41.2% during the second quarter. Amundi now owns 18,483,326 shares of the company’s stock worth $353,216,000 after purchasing an additional 5,392,413 shares in the last quarter. California State Teachers Retirement System lifted its position in Kenvue by 1,695.1% in the second quarter. California State Teachers Retirement System now owns 56,438,843 shares of the company’s stock worth $1,078,546,000 after purchasing an additional 53,294,807 shares during the period. Finally, Readystate Asset Management LP lifted its position in Kenvue by 18.9% in the second quarter. Readystate Asset Management LP now owns 1,257,316 shares of the company’s stock worth $24,027,000 after purchasing an additional 200,000 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analysts Set New Price Targets

KVUE has been the topic of several research analyst reports. UBS Group lowered their price target on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 11th. Wall Street Zen lowered Kenvue from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Barclays raised their target price on Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 21st. Weiss Ratings raised Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. Finally, Zacks Research cut shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. Three investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $19.27.

Kenvue Price Performance

Shares of NYSE KVUE traded down $0.35 during mid-day trading on Tuesday, reaching $18.39. The company had a trading volume of 16,219,959 shares, compared to its average volume of 27,713,732. The company has a 50-day moving average price of $19.18 and a two-hundred day moving average price of $18.26. The stock has a market cap of $35.31 billion, a PE ratio of 21.13, a P/E/G ratio of 1.67 and a beta of 0.46. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $20.13.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, August 6th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01). Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The company had revenue of $3.96 billion for the quarter, compared to analysts’ expectations of $3.97 billion. During the same period in the prior year, the company earned $0.29 earnings per share. The company’s revenue for the quarter was up 3.0% on a year-over-year basis. On average, equities analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th were paid a dividend of $0.21 per share. This is a boost from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.84 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date of this dividend was Wednesday, August 12th. Kenvue’s payout ratio is currently 96.55%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.